| Typicality: | 0.584 |
| Saliency: | 0.425 |
| to prove their efficacy | 3 | purpose |
| currently | 2 | temporal |
| drug → go through → clinical trials | 63 |
| drug → go through → trial | 4 |
| drug → go through → clinical trial | 3 |
| drug → gone through → clinical trial process | 3 |
| negative | neutral | positive |
| 0.182 | 0.702 | 0.116 |
| Raw frequency | 73 |
| Normalized frequency | 0.425 |
| Modifier score | 0.971 |
| Perplexity | 182.127 |